VIVO
Meridian Bioscience Inc
VIVO
VIVO
Delisted
VIVO was delisted on the 30th of January, 2023.
173 hedge funds and large institutions have $462M invested in Meridian Bioscience Inc in 2019 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 53 increasing their positions, 51 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
34% less capital invested
Capital invested by funds: $701M → $462M (-$239M)
Holders
173
Holding in Top 10
–
Calls
$569K
Puts
$226K
Top Buyers
| 1 | +$8.47M | |
| 2 | +$3.25M | |
| 3 | +$2.79M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$2.75M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.74M |
Top Sellers
| 1 | -$25.8M | |
| 2 | -$3.18M | |
| 3 | -$3.03M | |
| 4 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
-$2.9M |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$2.29M |